Emeis EMEIS
EURONEXT · France · Health Services
€10.32-0.51 (-4.71%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Emeis (WBO:ORP2) reports 6% like-for-like revenue growth and raises full-year EBITDA guidance to 12-14% growth, despite persistent net losses and cash flow headwinds.
PUTEAUX, France, July 30, 2026--Regulatory News: emeis (Paris:EMEIS):
PUTEAUX, France, July 29, 2026--Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729930934/en/
PUTEAUX, France, July 03, 2026--Regulatory News: Under the liquidity agreement entrusted by emeis (the "Company") (Paris:EMEIS) to Natixis Oddo BHF, the following resources were recorded in the dedicated liquidity account as of 30 June 2026:
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.